PTSD SOAP Note Example: Trauma-Focused Psychiatric Documentation
Dr. Medeline Yost
Chief Medical Officer, Augustun
Published July 11, 2026
Updated July 11, 2026
On this page
- Psychiatry-Focused PTSD Notes vs. Trauma SOAP Guides
- PTSD vs. Acute Stress: What to Document Differently
- PCL-5 and the Four Symptom Clusters
- Medication Management Specifics for PTSD
- Documenting PE, CPT, and EMDR Without Process-Note Content
- PTSD Psychiatric SOAP Note Template
- PTSD SOAP Note Examples
- Risk and Safety in Trauma-Focused Psychiatric Notes
- Common Mistakes in PTSD Psychiatric Documentation
- Let Augustun Draft Your PTSD Psychiatric Notes
- Conclusion
- FAQ
PTSD documentation in psychiatry is not the same as a general trauma therapy note. Psychiatrists and psychiatric nurse practitioners chart mental status, symptom clusters, rating scales, medication response, and risk — often alongside trauma-focused psychotherapy that someone else delivers. The note has to justify medical necessity, communicate with the treatment team, and stay audit-ready without becoming a psychotherapy process note.
This guide is psychiatry-focused: mental status exam (MSE), PCL-5 and DSM-5 symptom clusters, medications such as SSRIs and prazosin, and explicit risk formulation. For the broader trauma-informed SOAP framing used across counseling and therapy settings, see our companion guide on Trauma SOAP Notes. Use that post for trauma-informed phrasing across disciplines; use this one when the record is a psychiatric medical note.
Below you will find how PTSD differs from acute stress documentation, how to capture PCL-5 clusters cleanly, how to document medication and evidence-based trauma therapy progress without putting process-note content in the chart, a fillable SOAP template, four complete PTSD SOAP note examples, risk guidance, and the mistakes that most often weaken trauma-related psychiatric notes.
Psychiatry-Focused PTSD Notes vs. Trauma SOAP Guides
A PTSD SOAP note written for psychiatry lives in the official medical record. It centers diagnosis, severity, MSE findings, medication decisions, labs or monitoring when relevant, and a safety plan. Progress in prolonged exposure (PE), cognitive processing therapy (CPT), or EMDR belongs in the medical record only as treatment status and functional change — not as a transcript of session content, trauma narrative detail, or the clinician's private hypotheses.
Psychotherapy (process) notes are kept separately under HIPAA and are not part of the designated medical record. Do not paste session-by-session process material into a psychiatric SOAP note. Document modality, session number or phase, homework adherence, symptom/scale change, and any adverse reactions or grounding needs — then stop. Keep graphic trauma details out of the chart unless they are clinically necessary for safety or differential diagnosis, and even then keep them brief and non-sensational.
Companion reading
Need trauma-informed SOAP language for therapy and counseling contexts? Start with Trauma SOAP Notes. Need the general psychiatric SOAP structure (MSE placement, template, non-PTSD examples)? See our psychiatric SOAP note guide.
PTSD vs. Acute Stress: What to Document Differently
Timing and persistence drive the diagnostic distinction, and your note should make that logic visible. Acute stress disorder is considered when trauma-related symptoms begin immediately after a qualifying event and last from three days to one month. PTSD requires symptom persistence beyond one month (or delayed expression) across intrusion, avoidance, negative alterations in cognitions/mood, and arousal/reactivity clusters, with clinically significant distress or functional impairment.
- Document the index trauma in non-graphic terms (type, approximate timing, whether Criterion A is met) — not a narrative retelling.
- State duration since the event and since symptom onset; this is what separates acute stress from PTSD in the Assessment.
- Name which symptom clusters are present and how they impair work, relationships, sleep, or safety.
- If duration is still under one month, document acute stress (or trauma- and stressor-related symptoms) and a plan to reassess for PTSD at the one-month mark.
- Note delayed onset when symptoms emerge six months or more after the trauma.
Example Assessment language: 'PTSD, chronic (F43.10) — Criterion A motor vehicle collision 14 months ago; ongoing intrusion (nightmares, trauma cues), avoidance of driving and news coverage, persistent shame/blame cognitions, and hyperarousal with insomnia and exaggerated startle. Duration >1 month with occupational impairment. Not acute stress disorder given time course.'
PCL-5 and the Four Symptom Clusters
The PTSD Checklist for DSM-5 (PCL-5) is a 20-item self-report measure that maps to DSM-5 PTSD criteria. Recording the total score and which clusters drive impairment makes follow-up notes useful. A drop of roughly 5–10 points is often treated as reliable change; a larger drop (commonly cited around 10+) may suggest clinically meaningful improvement — always interpret in context of functioning and MSE.
| Cluster | What to capture in the note | Example phrasing |
|---|---|---|
| Intrusion | Nightmares, flashbacks, intrusive memories, cue distress | Nightmares 4–5 nights/week; flashbacks 2x this week after sirens |
| Avoidance | Avoidance of memories, people, places, conversations, media | Avoids highway driving and trauma-related news; skips anniversary events |
| Negative cognitions/mood | Blame, shame, detachment, anhedonia, persistent negative beliefs | Persistent self-blame; emotional numbing; withdrawal from friends |
| Arousal/reactivity | Irritability, hypervigilance, startle, sleep disturbance, reckless behavior | Exaggerated startle; sleeping 4 hours; scanning exits in public |
In Objective, write the score with meaning: 'PCL-5 = 48 (prior visit 57) — improved intrusion and sleep items; avoidance and hypervigilance largely unchanged.' Pair the scale with functional markers (returned to part-time work, still avoids nightlife, fewer panic episodes) so progress is not only a number.
Scales belong in Objective
PCL-5, PHQ-9, GAD-7, and similar measures sit in the Objective section with the MSE. Save interpretation of what the score means for severity and response for Assessment.
Medication Management Specifics for PTSD
First-line pharmacotherapy for PTSD often includes SSRIs such as sertraline or paroxetine (FDA-approved for PTSD) and commonly used off-label options such as fluoxetine or SNRIs like venlafaxine, depending on guidelines and patient factors. Document indication, dose, titration plan, adherence, side effects, and why you chose or changed the agent — the same discipline you would use in any psychiatric medication management note.
Prazosin is frequently used for trauma-related nightmares. When documenting prazosin, include nightmare frequency/intensity before and after titration, bedtime dosing, orthostatic symptoms (dizziness, syncope), blood pressure context when available, and whether daytime PTSD symptoms are also changing. Example: 'Continued prazosin 3 mg qHS; nightmares reduced from nightly to 2 nights/week; denies dizziness on standing; BP 118/74 seated.'
- SSRI/SNRI: start or adjust with rationale (partial response, tolerability, comorbidity such as MDD).
- Prazosin: target nightmare burden; titrate carefully; document orthostasis counseling.
- Avoid implying benzodiazepines as first-line PTSD treatment; if used short-term for another indication, state why and the exit plan.
- Note alcohol or cannabis use that may blunt therapy gains or interact with sedating meds.
- Coordinate with therapy: medication alone rarely replaces trauma-focused psychotherapy when that is indicated and available.
Documenting PE, CPT, and EMDR Without Process-Note Content
Evidence-based trauma therapies belong in the psychiatric medical record as treatment course and response, not as process notes. HIPAA distinguishes psychotherapy notes (personal process material) from the medical record. Your SOAP note should never contain a blow-by-blow of imaginal exposure content, EMDR target lists with trauma narrative detail, or the therapist's private case conceptualization.
Medical-record–appropriate language looks like this:
- Modality and phase: 'Week 6 of CPT; stuck-point worksheets ongoing; patient completing homework 4/7 days.'
- PE: 'In vivo hierarchy progressing; completed two planned exposures this week without dissociation requiring session stop.'
- EMDR: 'Reprocessing phase continued; patient tolerated session; used grounding at end; no adverse reaction overnight.'
- Response: 'Subjective distress with trauma cues down from 8/10 to 5/10; PCL-5 trending down; sleep improved.'
- Coordination: 'Therapist reports engagement; psychiatry managing sertraline and prazosin; next joint review in 4 weeks.'
If you are the psychiatrist co-managing with a therapist, document the collaborative plan without importing the therapist's process notes into your chart. If you deliver therapy yourself, still keep the medical note focused on symptoms, MSE, scales, risk, and plan — and keep process material in a separate psychotherapy note if your practice uses that distinction.
PTSD Psychiatric SOAP Note Template
Copy this skeleton for intake or follow-up med-management visits. Trim sections that do not apply, but keep risk and cluster coverage explicit.
PTSD Psychiatric SOAP Note — Template
- S (Subjective)
- Chief complaint in the patient's words. Trauma history in non-graphic terms (type, timing, Criterion A). Current intrusion, avoidance, negative cognition/mood, and arousal symptoms with frequency and functional impact. Nightmare burden if relevant. Medication adherence and side effects. Therapy modality/phase and homework adherence (no process detail). Substance use. Direct quotes that show impact. Sleep, appetite, work/relationship functioning.
- O (Objective) — Mental Status Exam
- Appearance, behavior (including hypervigilance, startle, dissociation signs). Speech. Mood (patient's words) and affect. Thought process and content (including trauma-related cognitions without graphic narrative). Perception. Cognition, orientation, concentration. Insight and judgment. PCL-5 (and PHQ-9/GAD-7 if used) with prior comparison. Vitals when relevant (e.g., prazosin monitoring).
- A (Assessment)
- PTSD diagnosis with ICD-10 and supporting clusters/duration. Specifiers (chronic, delayed, with dissociative symptoms) as applicable. Comorbidities (MDD, substance use, TBI). Differential (acute stress if <1 month; adjustment; other anxiety). Severity and change since last visit. Explicit suicide/homicide risk formulation with risk and protective factors. Medication response impression.
- P (Plan)
- Medication: continue/adjust SSRI/SNRI and/or prazosin with rationale. Therapy: PE/CPT/EMDR status and referrals. Safety plan and crisis resources. Patient education (meds, sleep, triggers). Labs/monitoring as indicated. Follow-up interval and what will be re-measured (PCL-5, nightmare frequency, MSE).
PTSD SOAP Note Examples
Names and details are illustrative. Each example keeps psychiatry-relevant structure: MSE, clusters or PCL-5, meds, and risk — without process-note content.
Example 1 — Outpatient PTSD Medication Management (Initial Visit)
Elena is a 38-year-old referred after a workplace assault 11 months ago. This is her first psychiatry visit for medication evaluation while she begins trauma-focused therapy elsewhere.
PTSD SOAP Note — Initial Med Management
- S (Subjective)
- 38-year-old female referred for PTSD medication evaluation. Index trauma: workplace physical assault 11 months ago (Criterion A met; details minimized per patient preference). Reports daily intrusive memories, nightmares most nights, avoidance of the workplace neighborhood and assault-related media, persistent self-blame ('I should have seen it coming'), emotional numbing, irritability, hypervigilance, and sleep limited to ~4 hours. States, 'I jump at every sudden noise.' Function: on leave from work; limited social contact. No prior psychotropic trials. Drinking 2–3 glasses of wine most nights 'to sleep.' Denies cannabis. Starting CPT with outside therapist next week.
- O (Objective)
- Casually dressed, tense posture, frequently scans room and doorway. Speech normal rate. Mood 'on edge'; affect anxious, congruent, reactive. Thought process linear. Thought content: trauma-related guilt cognitions; no delusions. No hallucinations. Oriented x3; concentration mildly impaired. Insight fair; judgment intact. No dissociation observed today. PCL-5 = 58. PHQ-9 = 14. BP 126/80, HR 86.
- A (Assessment)
- 1) Post-traumatic stress disorder (F43.10) — duration >1 month; all four DSM-5 clusters present with occupational impairment. 2) Major depressive disorder, moderate, single episode (F32.1) — overlapping anhedonia and low mood; PTSD primary for now. 3) Alcohol use, unspecified, mild symptoms — self-medicating insomnia; monitor. Not acute stress disorder given 11-month course. Suicide risk: denies SI/HI, plan, or intent; protective factors include therapy engagement and supportive partner — low acute risk. High symptom burden warrants combined pharmacotherapy and trauma-focused psychotherapy.
- P (Plan)
- Start sertraline 50 mg daily x1 week, then 100 mg daily if tolerated; discussed delayed onset, GI side effects, and rare activation. Start prazosin 1 mg qHS, titrate by 1 mg every 3–4 nights as tolerated for nightmares; counsel on orthostasis. Sleep hygiene; reduce alcohol toward abstinence given interference with PTSD recovery. Continue CPT with outside therapist; psychiatry will not document process content — track PCL-5 and nightmare frequency. Safety plan and crisis resources provided. Labs: CBC, CMP, TSH. Follow-up in 3 weeks with repeat PCL-5/PHQ-9.
Example 2 — Nightmare / Prazosin Follow-Up
Marcus is a 45-year-old veteran on sertraline returning specifically to titrate prazosin for residual nightmares.
PTSD SOAP Note — Prazosin Titration Follow-Up
- S (Subjective)
- 45-year-old male veteran with combat-related PTSD returns 4 weeks after starting prazosin. Nightmares decreased from nightly to 2–3 nights/week; intensity 'less vivid.' Still wakes abruptly with tachycardia on nightmare nights. Sertraline 150 mg daily — adherent; notes calmer daytime mood and fewer anger outbursts. Continues to avoid crowded stores. States, 'The meds help my sleep more than anything else has.' Mild dizziness once on standing after dose increase to 3 mg; resolved with slower rise. Weekly PE ongoing; completing in vivo homework. Denies new trauma exposure. Alcohol none.
- O (Objective)
- Well-groomed, mild psychomotor tension. Speech normal. Mood 'better but still wired'; affect anxious but brighter than prior visit. Thought process linear; no psychosis. Hypervigilant seating choice near exit. Oriented x3; cognition intact. Insight good. PCL-5 = 41 (was 52). Seated BP 118/74, standing BP 110/70 at 1 minute; no symptomatic orthostasis today.
- A (Assessment)
- PTSD (F43.10), combat-related — partial response. Intrusion (nightmares) and sleep improved on prazosin; residual avoidance and hyperarousal. Depressive symptoms improved on sertraline. Tolerating current regimen with one transient orthostatic episode after titration. Suicide/homicide risk: denies ideation — low risk; protective factors include family and treatment engagement. Continue combined meds + PE.
- P (Plan)
- Continue sertraline 150 mg daily. Increase prazosin from 3 mg to 4 mg qHS given residual nightmares 2–3x/week and reassuring orthostatic check; reinforce slow position changes. Continue PE with therapist; psychiatry documents response only (homework adherence, cue distress trend), not exposure content. Repeat PCL-5 next visit. Return in 4 weeks or sooner if dizziness, syncope, or worsening nightmares.
Example 3 — Trauma-Focused Therapy Progress (Medical-Record Appropriate)
Priya is mid-course in CPT. This note shows how to document therapy progress in a psychiatric chart without process-note content.
PTSD SOAP Note — CPT Progress (Medical Record)
- S (Subjective)
- 32-year-old female with PTSD related to interpersonal violence, month 3 of CPT (session ~10). Reports completing stuck-point worksheets most days. Subjective distress when encountering trauma reminders down from 8/10 to 5/10. Nightmares 1–2 nights/week (was 5–6). Still avoids dating but resumed grocery shopping alone. States, 'I still blame myself sometimes, but I can challenge it now.' On fluoxetine 40 mg — adherent, mild sexual side effects discussed previously and acceptable to patient. Denies SI. No new substance use.
- O (Objective)
- Appropriately dressed, relaxed posture compared with intake. Speech normal. Mood 'hopeful'; affect full and congruent. Thought process goal-directed. Trauma-related guilt cognitions present but patient able to generate alternative appraisals in session discussion (content summarized only — no narrative detail recorded). No dissociation. Oriented x3. Insight good. PCL-5 = 34 (intake 61; last month 42).
- A (Assessment)
- PTSD (F43.10) — clinically meaningful improvement on PCL-5 and functioning during CPT + fluoxetine. Residual avoidance and intermittent guilt cognitions expected at this phase. No acute safety concerns. Continue current combined treatment; medication stable.
- P (Plan)
- Continue fluoxetine 40 mg daily. Continue CPT through protocol completion; chart will reflect modality, adherence, scale trends, and functional gains only — psychotherapy process material remains outside the medical record. Safety plan reviewed (unchanged). Follow-up in 6 weeks with PCL-5; earlier if symptom rebound.
Example 4 — Complex PTSD / Comorbidity
Jordan presents with prolonged childhood trauma, dissociative symptoms, depression, and substance use — a documentation pattern that needs clear differentials and careful risk language.
PTSD SOAP Note — Complex Presentation / Comorbidity
- S (Subjective)
- 29-year-old nonbinary patient with prolonged childhood interpersonal trauma. Reports chronic emptiness, identity disturbance, and repeated interpersonal crises alongside classic PTSD clusters: intrusive memories, avoidance of family contact, pervasive shame, and severe hyperarousal. Dissociative episodes ('I lose time') several times per week, usually after conflict. Cannabis daily; last alcohol binge 10 days ago. Nightmares most nights. Prior trials of sertraline (partial) and bupropion (worsened anxiety). States, 'Some days I don't care if I wake up, but I don't have a plan.' Engaged in DBT skills group; EMDR deferred until stabilization.
- O (Objective)
- Casually dressed, intermittent eye contact, mild psychomotor agitation. Brief staring spell ~20 seconds mid-interview; responded to grounding (feet on floor, 5-senses) and returned to baseline. Speech soft. Mood 'numb and tired'; affect constricted with tearfulness when discussing shame. Thought process linear. No psychosis. Oriented x3 after grounding. Insight partial; judgment fair. PCL-5 = 64. PHQ-9 = 19. Urine tox pending.
- A (Assessment)
- 1) PTSD (F43.10) with dissociative symptoms — prolonged trauma, all clusters, high PCL-5. Complex PTSD features (affect dysregulation, negative self-concept, relational disturbance) noted clinically; document DSM-5 PTSD formally while tracking complex features for treatment planning. 2) Major depressive disorder, recurrent, moderate (F33.1). 3) Cannabis use disorder, mild; alcohol use — recent binge. R/O borderline personality disorder traits vs. trauma-related affective instability — defer personality diagnosis while acute PTSD/depression treated. Suicide risk: passive death wish without plan/intent; risk factors include dissociation, substance use, and isolation; protective factors include DBT engagement and housing stability — moderate risk, outpatient appropriate with close follow-up and updated safety plan.
- P (Plan)
- Start venlafaxine XR 37.5 mg daily, titrate toward 75–150 mg as tolerated for PTSD/depression (prior SSRI partial response). Prazosin 1 mg qHS for nightmares with orthostasis counseling. Hold trauma memory reprocessing until improved stabilization per collaborative plan with therapist; psychiatry documents phase of care (stabilization), not process content. Continue DBT skills group. Substance: harm-reduction counseling; reduce cannabis; no alcohol. Safety plan updated; crisis line and ED instructions reviewed; agree to contact supports if passive SI becomes active. Labs/tox. Follow-up in 1–2 weeks given risk level; sooner if SI intensifies.
Risk and Safety in Trauma-Focused Psychiatric Notes
Trauma-related visits require explicit, visit-level risk documentation. Passive death wishes, self-harm urges, dissociative gaps, unsafe relationships, and substance-related impulsivity are common and must be named without dramatizing trauma content.
- Screen for suicidal ideation, plan, intent, and means every visit — document positives and negatives.
- Include homicide/violence risk when irritability, paranoia, or revenge ideation is present.
- List risk factors (isolation, substances, prior attempts, access to firearms) and protective factors (children, treatment alliance, housing, faith, future plans).
- Update the safety plan when symptoms or circumstances change; note that it was reviewed.
- If dissociation occurred in session, document duration, intervention used, and return to baseline.
- Avoid graphic trauma narrative in the risk section; focus on current thoughts, behaviors, and supports.
Strong phrasing example: 'Acknowledges passive wish not to wake some mornings; denies plan, intent, and preparatory behavior. No prior attempts. Firearms secured per patient report. Protective factors: children, weekly therapy, and willingness to use crisis line. Safety plan reviewed and reaffirmed. Risk: low-to-moderate, appropriate for outpatient care with close follow-up.'
Common Mistakes in PTSD Psychiatric Documentation
Putting psychotherapy process notes in the medical record
Session transcripts, detailed trauma narratives, and private hypotheses belong outside the designated medical record when they qualify as psychotherapy notes. In the SOAP note, stick to modality, adherence, scales, functioning, meds, MSE, and risk.
Writing graphic trauma detail that is not needed
Criterion A can usually be documented as trauma type and timing. Extra graphic detail rarely improves care and can harm the patient if the record is later disclosed. Prefer symptoms and impairment over storytelling.
Skipping clusters or treating PTSD as 'anxiety'
A note that only says 'anxious after trauma' under-documents PTSD. Name intrusion, avoidance, negative cognitions/mood, and arousal — or explain why criteria are not met.
Vague medication rationale
'Continue meds' without dose, target symptom, or response is weak. For prazosin especially, document nightmare frequency and orthostatic counseling. For SSRIs, document indication, titration, and side effects.
Missing risk documentation
Trauma notes without SI/HI screening are a liability gap. A documented negative is protective. If risk is elevated, your Plan must match (closer follow-up, safety plan update, higher level of care).
Confusing acute stress with PTSD
If symptoms are still within the first month after trauma, say so and plan reassessment. Labeling early post-trauma symptoms as PTSD can confuse longitudinal care and billing logic.
Let Augustun Draft Your PTSD Psychiatric Notes
Trauma-focused psychiatric visits are dense: MSE, PCL-5 trends, medication decisions, therapy phase, and risk all need to land in the chart while you stay present with the patient. Augustun for psychiatry listens during the encounter and drafts a structured SOAP note — including mental status, scale capture, and a clear plan — in seconds. You review, edit, and sign.
Augustun supports SOAP and other behavioral health formats, suggests ICD-10 coding, and connects to 400+ EHRs through a browser extension so finished notes land where you already chart. It is built for clinical use with HIPAA compliance, and recordings are never stored. For broader psychiatry documentation habits beyond PTSD, see how to write psychiatry notes.
Built for behavioral health documentation
Whether you are documenting an initial PTSD med evaluation, a prazosin titration, or a comorbidity-heavy follow-up, Augustun adapts to your format so you spend less time charting and more time on trauma-informed care.
AI-Powered · HIPAA-Ready
Draft PTSD SOAP notes without losing the visit
See how Augustun captures MSE, symptoms, and medication plans for psychiatry — then review and sign in your EHR.
No credit card required.
Conclusion
A strong PTSD SOAP note in psychiatry is explicit about clusters and duration, carries a full MSE and PCL-5 when used, justifies SSRI and prazosin decisions, documents trauma therapy as course and response — never as a process note — and states risk with protective factors every visit. Keep graphic narrative out of the medical record, differentiate PTSD from acute stress by time course, and let Assessment show your reasoning so Plan can answer it.
Start from the template, adapt one of the four examples to your patient, and pair this psychiatry-focused guide with Trauma SOAP Notes when you need broader trauma-informed phrasing. Clear PTSD documentation protects patients, supports medical necessity, and makes the next clinician's job easier.
Frequently asked questions
How is a PTSD SOAP note different from a general trauma SOAP note?
A psychiatry-focused PTSD SOAP note emphasizes mental status exam, DSM-5/PCL-5 symptom clusters, medication management (e.g., SSRIs, prazosin), ICD-10 formulation, and visit-level risk assessment in the official medical record. Broader trauma SOAP guides often speak to counseling and therapy workflows. Use this post for psychiatric medical documentation and the Trauma SOAP Notes companion for cross-disciplinary trauma-informed phrasing.
Should I put PE, CPT, or EMDR process details in the psychiatric SOAP note?
No. Document modality, phase or session progress at a high level, homework adherence, symptom/scale change, tolerability, and coordination of care. Do not place psychotherapy process notes — detailed trauma narratives, target lists with graphic content, or private clinician hypotheses — in the medical record. Keep process material separate under HIPAA psychotherapy-note protections when your practice uses that distinction.
What should I document when prescribing prazosin for PTSD nightmares?
Record baseline and follow-up nightmare frequency and intensity, bedtime dose and titration steps, adherence, orthostatic symptoms (dizziness, syncope), blood pressure when checked, counseling provided, and whether daytime PTSD symptoms are also changing. Tie the medication decision to the intrusion/sleep burden in Assessment and Plan.
How do I document PTSD vs. acute stress disorder?
State the time since the traumatic event and since symptom onset. Acute stress disorder applies when symptoms last from three days to one month after trauma. PTSD requires persistence beyond one month (or delayed expression) with clinically significant impairment across the relevant clusters. Make that duration logic explicit in Assessment and plan to reassess if the patient is still within the first month.
Can an AI scribe help with PTSD psychiatric SOAP notes?
Yes. An ambient AI scribe like Augustun can draft a structured psychiatric SOAP note from the visit — including MSE elements, symptom capture, and plan language — for you to review and sign. It is HIPAA compliant, does not store recordings, and integrates with 400+ EHRs via browser extension. You remain responsible for clinical accuracy, risk language, and keeping process-note content out of the medical record.
AI-Powered · HIPAA-Ready
Spend more time with patients, not paperwork.
Augustun transforms ambient speech into accurate notes — finished before your next session.
No credit card required.

Dr. Medeline Yost
Chief Medical Officer, Augustun
Dr. Medeline Yost is an Internal Medicine physician and an emerging leader in clinical innovation. As Chief Medical Officer at Augustun, she helps shape AI-powered tools that streamline clinical documentation and support physicians in delivering higher-quality care. Her professional interests include medical education, workflow redesign, and the responsible use of AI in healthcare — building systems that let clinicians spend more time with patients and less on administrative tasks.